Form D Explorer

Form D — ProPhase Labs, Inc.

0001641172-25-017941 · filed 2025-07-07

Offering

Industry
Biotechnology
Exemptions
06b
Total offering
$1,000,000
Total sold
$1,000,000
Minimum investment
$500,000
Investors
Sales commission
Finders' fees

Issuer

Name
ProPhase Labs, Inc.
CIK
868278
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
Address
626 RXR PLAZA, 6TH FLOOR
UNIONDALE, NY 11556
Phone
215-345-0919

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View original on SEC EDGAR.